US2022313674A1PendingUtilityA1
Psilocybin compositions
Est. expiryJul 23, 2036(~10 yrs left)· nominal 20-yr term from priority
Inventors:Paul Edward Stamets
A61K 36/07A61K 31/455A61K 31/675A61K 31/4045
80
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A composition comprising:
psilocybin, psilocin, baeocystin, norbaeocystin, N,N-dimethyltryptamine (DMT), or a combination thereof; and an extract of Hericium erinaceus.
2 . The composition of claim 1 , further comprising niacin.
3 . The composition of claim 1 , further comprising neurotropic or nootropic fungal or plant extracts, or other natural products, or purified compounds thereof.
4 . A composition comprising:
an extract of Hericium erinaceus; and niacin.
6 . The composition of claim 4 , further comprising psilocybin, psilocin, baeocystin, norbaeocystin, N,N-dimethyltryptamine (DMT), or a combination thereof.
7 . The composition of claim 4 , further comprising neurotropic or nootropic fungal or plant extracts, or other natural products, or purified compounds thereof.
8 . A composition comprising:
psilocybin, psilocin, baeocystin, norbaeocystin, N,N-dimethyltryptamine (DMT), or a combination thereof; and niacin.
9 . The composition of claim 8 , further comprising an extract of Hericium erinaceus.
10 . The composition of claim 8 , further comprising neurotropic or nootropic fungal or plant extracts, or other natural products, or purified compounds thereof.
11 . A method for inducing one or more of neurogenesis, neuroregeneration, neurogeneration, and neuroplasticity in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
psilocybin, psilocin, baeocystin, norbaeocystin, N,N-dimethyltryptamine (DMT), or a combination thereof; and an extract of Hericium erinaceus.
12 . The composition of claim 11 , further comprising niacin.
13 . A method for inducing one or more of neurogenesis, neuroregeneration, neurogeneration, and neuroplasticity in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
an extract of Hericium erinaceus; and niacin.
14 . The composition of claim 13 , further comprising psilocybin, psilocin, baeocystin, norbaeocystin, N,N-dimethyltryptamine (DMT), or a combination thereof.
15 . A method for inducing one or more of neurogenesis, neuroregeneration, neurogeneration, and neuroplasticity in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
psilocybin, psilocin, baeocystin, norbaeocystin, N,N-dimethyltryptamine (DMT), or a combination thereof; and niacin.
16 . The composition of claim 15 , further comprising an extract of Hericium erinaceus.
17 . A method for treating mental health in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
psilocybin, psilocin, baeocystin, norbaeocystin, N,N-dimethyltryptamine (DMT), or a combination thereof; and an extract of Hericium erinaceus.
18 . The composition of claim 17 , further comprising niacin.
19 . A method for treating mental health in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
an extract of Hericium erinaceus; and niacin.
20 . The composition of claim 19 , further comprising psilocybin, psilocin, baeocystin, norbaeocystin, N,N-dimethyltryptamine (DMT), or a combination thereof.
21 . A method for treating mental health in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
psilocybin, psilocin, baeocystin, norbaeocystin, N,N-dimethyltryptamine (DMT), or a combination thereof; and niacin.
22 . The composition of claim 21 , further comprising an extract of Hericium erinaceus.Join the waitlist — get patent alerts
Track US2022313674A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.